Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled
Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled. // Cell Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2590136226001191?dgcid=rss_sd_all
Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled. Cell Reports. https://www.sciencedirect.com/science/article/pii/S2590136226001191?dgcid=rss_sd_all
“Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled.” Cell Reports.
@article{article11430,
title = {Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled},
journal = {Cell Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2590136226001191?dgcid=rss_sd_all}
}